A Reticulocyte Count (often called a retic count) is a blood test that measures how many reticulocytes—newly made, immature red blood cells—are circulating in your bloodstream. Reticulocytes are produced in the bone marrow and then released into the blood, where they mature into fully functioning red blood cells within about 1–2 days.

This test is a key way to assess your body’s bone marrow response and overall red blood cell production (erythropoiesis). Results may be reported as a percentage of red blood cells that are reticulocytes and/or as an absolute reticulocyte count (the actual number of reticulocytes in a given volume of blood). In many anemia evaluations, clinicians may also consider adjusted values such as the corrected reticulocyte count or reticulocyte production index (RPI) to better judge whether the bone marrow response is appropriate for the degree of anemia.

In plain language, the result helps answer an important question during an anemia workup: Is your body making enough new red blood cells?

How to interpret results in general terms (your clinician will interpret in context):

Higher-than-expected reticulocytes often mean the bone marrow is working harder to replace red blood cells—commonly seen after blood loss or when red blood cells are being destroyed faster than normal (hemolysis). A higher retic count can also be seen when you are recovering after treatment for certain anemias (for example, after iron, vitamin B12, or folate therapy), as the marrow “catches up.”

Lower-than-expected reticulocytes may mean the bone marrow is not producing enough red blood cells. This can occur with iron deficiency, vitamin B12 or folate deficiency, chronic inflammation or kidney disease (reduced erythropoietin), bone marrow disorders, or medication/toxin effects. In someone with anemia, a low reticulocyte count suggests the body is not mounting an adequate production response.

A reticulocyte count is commonly ordered as part of an anemia workup or to evaluate abnormal findings on a complete blood count (CBC)—especially low hemoglobin/hematocrit or changes in red blood cell indices. It helps determine whether anemia is due to decreased production of red blood cells or increased loss/destruction of red blood cells.

Your healthcare provider may order this test if you have symptoms that could be related to anemia or red blood cell problems, such as:

Unusual fatigue, weakness, shortness of breath with activity, dizziness, headaches, paleness, rapid heartbeat, or decreased exercise tolerance. Depending on the cause, people may also have jaundice (yellowing of the skin/eyes), dark urine, or abdominal discomfort—symptoms that can point toward red blood cell breakdown.

It may also be ordered in these situations:

Suspected or known blood loss (heavy menstrual bleeding, gastrointestinal bleeding, trauma, or after surgery) to see if the bone marrow is responding appropriately.

Possible hemolytic anemia (when red blood cells are destroyed early) to assess whether the bone marrow is increasing output to compensate.

Monitoring treatment response for anemia—such as after starting iron supplements, vitamin B12 injections, folate, or erythropoietin—because reticulocytes often rise before hemoglobin improves.

Evaluation of bone marrow function when production is suspected to be low (for example, after certain chemotherapy regimens, with marrow-suppressing medications, or with suspected bone marrow failure).

Kidney disease evaluation when anemia is present, since reduced erythropoietin can limit reticulocyte production.

Because many factors influence the retic count, it’s typically interpreted alongside other labs such as the CBC, peripheral blood smear, iron studies (ferritin, iron, TIBC), vitamin B12 and folate levels, bilirubin, LDH, haptoglobin, and sometimes erythropoietin levels.

• Iron deficiency anemia
• Vitamin B12 deficiency anemia (megaloblastic anemia)
• Folate deficiency anemia
• Hemolytic anemia (including autoimmune hemolytic anemia)
• Sickle cell disease and other hemoglobin disorders
• Thalassemia
• Acute or chronic blood loss (e.g., gastrointestinal bleeding, heavy menstrual bleeding)
• Anemia of chronic disease/inflammation
• Chronic kidney disease–related anemia (low erythropoietin)
• Aplastic anemia and other bone marrow failure syndromes
• Bone marrow suppression from chemotherapy, radiation, or certain medications

• Identifying the cause of anemia and guiding an appropriate anemia workup
• Checking bone marrow response and red blood cell production (erythropoiesis) over time
• Monitoring recovery after blood loss, surgery, or hospitalization
• Tracking response to iron, vitamin B12, or folate treatment (early indicator of improvement)
• Supporting management of chronic conditions linked to anemia (e.g., chronic kidney disease or chronic inflammatory disorders)
• Evaluating suspected red blood cell destruction (hemolysis) and monitoring related care plans